Anti-Infective Agents

Compounds having the formula are hepatitis C(HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C(HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.

Saved in:
Bibliographic Details
Main Authors BOSSE TODD D, BETEBENNER DAVID A, HUTCHINSON DOUGLAS K, BORCHARDT THOMAS B, HUANG PEGGY P, ROCKWAY TODD W, FLENTGE CHARLES A, GATES BRADLEY D, CINK RUSSELL D, HINMAN MIRA M, MADIGAN DAROLD L, BISHOP RICHARD D, GREEN BRIAN E, STOLL VINCENT S, WAGNER ROLF, KLEIN LARRY L, ROSENBERG TERESA A, RANDOLPH JOHN T, KRUEGER ALLAN C, LIU DACHUN, LEANNA M. ROBERT, MCDANIEL KEITH F, LARSON DANIEL P, BELLETTINI JOHN R, YEUNG MING C, STEWART KENT D
Format Patent
LanguageEnglish
Published 14.08.2008
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Compounds having the formula are hepatitis C(HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C(HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.
Bibliography:Application Number: US20080098024